Stock INTS INTENSITY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Intensity Therapeutics, Inc.

Equities

INTS

US45828J1034

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-10 EDT 		5-day change 1st Jan Change
4 USD +6.38% Intraday chart for Intensity Therapeutics, Inc. +3.63% -53.33%
05-10 Intensity Therapeutics Collaborates With Swiss Group on Clinical Research for Breast Cancer Trial MT
05-10 Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Neutral

Neutral

Resistance 4.200 9.880 8.570
Spread/Res.-4.76%-59.51%-53.33%
Spread/Supp.+6.67%+90.48%+90.48%
Support 3.750 2.100 2.100

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. INTS Stock
  4. Charts Intensity Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW